Vera Therapeutics (VERA) Short Interest Ratio & Short Volume $21.64 -0.65 (-2.92%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$22.06 +0.42 (+1.94%) As of 08/29/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vera Therapeutics Short Interest DataVera Therapeutics (VERA) has a short interest of 7.57 million shares, representing 15.87% of the float (the number of shares available for trading by the public). This marks a -8.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.5, indicating that it would take 4.5 days of the average trading volume of 1.80 million shares to cover all short positions.Current Short Interest7,570,000 sharesPrevious Short Interest8,240,000 sharesChange Vs. Previous Month-8.13%Dollar Volume Sold Short$157.38 millionShort Interest Ratio4.5 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares63,824,000 sharesFloat Size47,690,000 sharesShort Percent of Float15.87%Today's Trading Volume2,121,800 sharesAverage Trading Volume1,796,484 sharesToday's Volume Vs. Average118% Short Selling Vera Therapeutics? Sign up to receive the latest short interest report for Vera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVERA Short Interest Over TimeVERA Days to Cover Over TimeVERA Percentage of Float Shorted Over Time Vera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20257,570,000 shares $157.38 million -8.1%15.9%4.5 $20.79 7/15/20258,240,000 shares $191.17 million +5,059.7%18.1%4.8 $23.20 6/30/2025159,700 shares $3.76 million -98.3%0.2%0.7 $23.56 6/15/20259,560,000 shares $217.39 million +6.8%20.8%5.5 $22.74 5/31/20258,950,000 shares $170.23 million +26.6%18.6%5.7 $19.02 5/15/20257,070,000 shares $150.80 million +18.6%14.7%7.1 $21.33 4/30/20255,960,000 shares $139.29 million -2.0%12.2%5.4 $23.37 4/15/20256,080,000 shares $131.27 million -7.0%12.4%6.4 $21.59 3/31/20256,540,000 shares $157.09 million -9.8%13.4%7 $24.02 3/15/20257,250,000 shares $202.93 million -7.1%14.8%8.6 $27.99 Get the Latest News and Ratings for VERA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20257,800,000 shares $233.45 million -6.7%15.9%9.8 $29.93 2/15/20258,360,000 shares $229.57 million +3.2%17.2%11 $27.46 1/31/20258,100,000 shares $301.97 million +11.1%16.6%12.2 $37.28 1/15/20257,290,000 shares $246.99 million +2.0%14.9%9.2 $33.88 12/31/20247,150,000 shares $302.37 million +5.2%14.6%9.8 $42.29 12/15/20246,800,000 shares $299.54 million +4.3%13.9%9.3 $44.05 11/30/20246,520,000 shares $324.37 million -0.5%13.3%8.6 $49.75 11/15/20246,550,000 shares $303.00 million +2.5%14.0%8.7 $46.26 10/31/20246,390,000 shares $258.03 million +3.2%13.3%9 $40.38 10/15/20246,190,000 shares $248.90 million +0.3%14.9%11.7 $40.21 9/30/20246,170,000 shares $272.71 million -4.5%14.9%11.3 $44.20 9/15/20246,460,000 shares $242.31 million +6.8%15.6%11.6 $37.51 8/31/20246,050,000 shares $228.81 million -0.5%14.6%11.3 $37.82 8/15/20246,080,000 shares $226.42 million -0.2%14.7%9.9 $37.24 7/31/20246,090,000 shares $222.83 million +1.7%14.7%9.4 $36.59 7/15/20245,990,000 shares $220.13 million -2.1%14.4%8.2 $36.75 6/30/20246,120,000 shares $221.42 million -0.1%14.7%6.9 $36.18 6/15/20246,123,800 shares $220.58 million +0.9%14.7%6.7 $36.02 5/31/20246,070,000 shares $230.60 million -6.0%14.5%6.6 $37.99 5/15/20246,460,000 shares $275.78 million -5.0%15.5%6.7 $42.69 4/30/20246,800,000 shares $268.67 million +7.8%16.6%6.5 $39.51 4/15/20246,310,000 shares $293.60 million -0.3%16.1%4.5 $46.53 3/31/20246,330,000 shares $272.95 million +1.4%16.1%4.9 $43.12 3/15/20246,240,000 shares $269.88 million +0.7%16.2%5.1 $43.25 2/29/20246,200,000 shares $291.90 million -8.4%16.5%5.3 $47.08 2/15/20246,770,000 shares $308.10 million +2.4%19.6%6.3 $45.51 1/31/20246,610,000 shares $240.74 million +9.3%19.1%6.6 $36.42 1/15/20246,050,000 shares $114.65 million -3.7%21.5%10.3 $18.95 12/31/20236,280,000 shares $96.59 million +11.2%22.2%11.3 $15.38 12/15/20235,650,000 shares $90.40 million +5.6%20.0%10.7 $16.00Washington prepares for war (Ad)While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.Click here now to watch the urgent wartime exposé 11/30/20235,350,000 shares $72.49 million +6.6%19.0%9.3 $13.55 11/15/20235,020,000 shares $67.07 million +1.2%17.8%8.5 $13.36 10/31/20234,960,000 shares $51.68 million -9.3%17.8%8.8 $10.42 10/15/20235,470,000 shares $58.20 million +11.9%19.9%10.7 $10.64 9/30/20234,890,000 shares $67.04 million +32.9%17.8%10.3 $13.71 9/15/20233,680,000 shares $62.89 million -2.9%13.4%7.3 $17.09 8/31/20233,790,000 shares $67.05 million +15.9%13.8%5.4 $17.69 8/15/20233,270,000 shares $57.85 million +6.2%11.9%4.7 $17.69 7/31/20233,080,000 shares $57.81 million -8.3%11.1%4.5 $18.77 7/15/20233,360,000 shares $56.92 million -2.6%12.3%5 $16.94 6/30/20233,450,000 shares $55.37 million -3.1%12.7%5.1 $16.05 6/15/20233,560,000 shares $45.28 million +24.5%13.4%5.6 $12.72 5/31/20232,860,000 shares $23.88 million -5.0%10.8%7.3 $8.35 5/15/20233,010,000 shares $23.99 million -9.1%11.3%7.5 $7.97 4/30/20233,310,000 shares $22.01 million +30.3%14.2%7.1 $6.65 4/15/20232,540,000 shares $15.93 million -28.9%9.7%4.6 $6.27 3/31/20233,570,000 shares $27.70 million +32.7%14.2%5.4 $7.76 3/15/20232,690,000 shares $19.18 million +15.5%10.7%3.2 $7.13 2/28/20232,330,000 shares $17.31 million +3.6%9.1%3 $7.43 2/15/20232,250,000 shares $17.71 million +47.1%8.8%3.1 $7.87 1/31/20231,530,000 shares $12.97 million +23.4%7.6%2.3 $8.48 1/15/20231,240,000 shares $8.36 million -12.1%9.3%2.4 $6.74 12/30/20221,410,000 shares $27.28 million -7.2%10.6%3.4 $19.35 12/15/20221,520,000 shares $29.14 million -22.1%11.4%11.7 $19.17 11/30/20221,950,000 shares $32.57 million -4.9%14.7%16 $16.70 11/15/20222,050,000 shares $34.54 million +15.8%15.5%18.9 $16.85 10/31/20221,770,000 shares $32.99 million +10.6%14.7%18.1 $18.64 10/15/20221,600,000 shares $30.69 million -1.2%13.3%18.6 $19.18 9/30/20221,620,000 shares $34.52 million +14.9%13.4%18.8 $21.31 9/15/20221,410,000 shares $30.13 million -10.2%11.7%16.2 $21.37 8/31/20221,570,000 shares $34.12 million +4.0%13.2%18 $21.73 8/15/20221,510,000 shares $32.69 million +14.4%12.6%18.9 $21.65 7/31/20221,320,000 shares $22.77 million +16.8%11.1%15 $17.25 7/15/20221,130,000 shares $18.14 million +20.1%9.5%12 $16.05 6/30/2022941,300 shares $12.81 million +28.2%7.9%10.2 $13.61 6/15/2022734,500 shares $10.28 million +83.6%6.2%8.2 $13.99 5/31/2022400,000 shares $5.82 million -12.5%3.3%4.1 $14.54 5/15/2022456,900 shares $6.99 million +8.1%3.8%4.7 $15.29 4/30/2022422,600 shares $8.45 million +41.2%3.4%3.6 $20.00 4/15/2022299,200 shares $6.92 million -46.3%2.4%2.7 $23.12 3/31/2022557,000 shares $13.08 million +40.1%4.5%5.3 $23.49 3/15/2022397,700 shares $9.55 million +39.1%3.1%3.6 $24.01 2/28/2022286,000 shares $6.64 million -16.7%2.2%2.8 $23.21 2/15/2022343,400 shares $6.81 million -4.3%3.7%3.5 $19.83 1/31/2022358,800 shares $7.15 million +27.9%4.9%5.2 $19.93 1/15/2022280,600 shares $5.61 million +15.6%3.8%4.6 $19.99 12/31/2021242,700 shares $6.48 million +185.2%3.3%4.2 $26.72 12/15/202185,100 shares $1.92 million +7.2%1.2%1.4 $22.51 11/30/202179,400 shares $2.84 million -36.6%1.1%1 $35.80 11/15/2021125,200 shares $2.93 million -32.4%1.7%1.6 $23.40Washington prepares for war (Ad)While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.Click here now to watch the urgent wartime exposé 10/29/2021185,100 shares $3.58 million +43.8%2.5%2.6 $19.35 10/15/2021128,700 shares $1.93 million +15.8%1.7%1.8 $15.01 9/30/2021111,100 shares $1.93 million +376.8%1.5%1.7 $17.35 9/15/202123,300 shares $712.98 thousand +651.6%0.3%0.4 $30.60 8/31/20213,100 shares $45.69 thousand +24.0%0.0%0.1 $14.74 8/13/20212,500 shares $42.35 thousand No Change0.0%0.1 $16.94 VERA Short Interest - Frequently Asked Questions What is Vera Therapeutics' current short interest? Short interest is the volume of Vera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 7,570,000 shares of VERA short. 15.87% of Vera Therapeutics' shares are currently sold short. Learn More on Vera Therapeutics' current short interest. What is a good short interest ratio for Vera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERA shares currently have a short interest ratio of 4.0. Learn More on Vera Therapeutics's short interest ratio. Which institutional investors are shorting Vera Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vera Therapeutics: Group One Trading LLC, Jane Street Group LLC, Walleye Capital LLC, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.87% of Vera Therapeutics' floating shares are currently sold short. Is Vera Therapeutics' short interest increasing or decreasing? Vera Therapeutics saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 7,570,000 shares, a drop of 8.1% from the previous total of 8,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vera Therapeutics' float size? Vera Therapeutics currently has issued a total of 63,820,000 shares. Some of Vera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vera Therapeutics currently has a public float of 47,690,000 shares. How does Vera Therapeutics' short interest compare to its competitors? 15.87% of Vera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vera Therapeutics: Nuvalent, Inc. (11.99%), Merus N.V. (6.44%), CRISPR Therapeutics AG (26.94%), TG Therapeutics, Inc. (16.53%), Cytokinetics, Incorporated (13.26%), Krystal Biotech, Inc. (13.61%), ACADIA Pharmaceuticals Inc. (8.89%), ADMA Biologics Inc (5.96%), Vaxcyte, Inc. (10.57%), PTC Therapeutics, Inc. (8.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Vera Therapeutics stock? Short selling VERA is an investing strategy that aims to generate trading profit from Vera Therapeutics as its price is falling. VERA shares are trading down $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vera Therapeutics? A short squeeze for Vera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VERA, which in turn drives the price of the stock up even further. How often is Vera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies NUVL Short Interest MRUS Short Interest CRSP Short Interest TGTX Short Interest CYTK Short Interest KRYS Short Interest ACAD Short Interest ADMA Short Interest PCVX Short Interest PTCT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VERA) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERA Stock Alerts